The skin is the most sensitive region of the body. The inflammation of this area is mainly due to stressful conditions, environmental conditions and irritation due to psoriasis and dermatitis, which cause itching and redness.

Thanks to in vivo and in vitro studies, Capsilence® is able to reduce the inflammatory mediators responsible for itching and inflammatory activities. In in vivo studies 40 individuals were tested: the solution containing Capsilence® reduced the itching sensation by 20% compared to the placebo solution, demonstrating how this innovative molecule protects against inflammatory phenomena of the skin.

Do you want to know more about Antalgenics product? Download the brochure:

L’Azienda

AntalGenics was founded in 2015 at the Spanish University Miguel Hernandez and is a biotech company based on the production and research of new active molecules for biomedical and dermocosmetic use. AntalGenics provides customized research and development services by designing and developing projects based on customer needs for the cosmetic world.